Phase
Condition
N/ATreatment
Rapid Expiratory Occlusion Monitor (REOM)
Standard oscillometry
Standard pulmonary function test
Clinical Study ID
Ages > 40 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Males and females aged ≥40 with COPD, former/current smokers with a ≥10 pack-yearsmoking history.
Diagnosed with COPD by FEV1/FVC < 0.7 using standard PFT post-bronchodilatortesting, with either 'mild' ('GOLD 1': FEV1 ≥ 80% of predicted value) COPD or 'verysevere' ('GOLD 4': FEV1 < 30% of predicted value) COPD.
Ability to provide informed consent.
Exclusion
Exclusion Criteria:
No existing COPD diagnosis
History of co-morbid asthma
Current use of home oxygen
Any acute exacerbation of COPD (AECOPD) experienced within 4 weeks of participationin the study
Chronic respiratory infection
Any contraindication to respiratory testing
Inability to participate in reproducible measurements due to physical or cognitivebarrier
Study Design
Study Description
Connect with a study center
McGill University Health Centre
Montréal, Quebec H4A 3J1
CanadaSite Not Available


Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.